Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

690 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Anti-tumor activity and biomarker analysis for TROP2-antibody drug conjugate Datopotamab deruxtecan in patient-derived breast cancer xenograft models.
Meric-Bernstam F, Yuca E, Evans KW, Zhao M, Maejima T, Karibe T, Raso MG, Tang X, Zheng X, Rizvi YQ, Akcakanat A, Scott SS, Wang B, Byers LA, Tripathy D, Okajima D, Damodaran S. Meric-Bernstam F, et al. Clin Cancer Res. 2024 Nov 25. doi: 10.1158/1078-0432.CCR-24-1948. Online ahead of print. Clin Cancer Res. 2024. PMID: 39585341
Genomic Alterations in DNA Mismatch Repair Genes Across Different Cancer Types.
Holla VR, Kahle MP, Kim SH, Ronaghy A, Yang RK, Patel KP, Routbort MJ, Overman MJ, Dumbrava EE, Mills Shaw KR, Karp DD, Meric-Bernstam F. Holla VR, et al. Among authors: meric bernstam f. JCO Precis Oncol. 2024 Nov;8:e2400419. doi: 10.1200/PO-24-00419. Epub 2024 Nov 22. JCO Precis Oncol. 2024. PMID: 39576951
Genomic and transcriptomic analyses identify distinctive features of triple-negative inflammatory breast cancer.
Wang X, Zhao L, Song X, Wu X, Krishnamurthy S, Semba T, Shao S, Knafl M, Coffer LW 2nd, Alexander A, Vines A, Bopparaju S, Woodward WA, Chu R, Zhang J, Yam C, Loo LWM, Nasrazadani A, Huong LP, Woodman SE, Futreal A; Rare Tumor Initiative Team; Tripathy D, Ueno NT. Wang X, et al. NPJ Precis Oncol. 2024 Nov 18;8(1):265. doi: 10.1038/s41698-024-00729-0. NPJ Precis Oncol. 2024. PMID: 39558017 Free PMC article.
Outcomes After Palliative Radiotherapy in Patients with Symptomatic Locoregionally Advanced Breast Cancer.
Jacomina LE, Swanson DM, Mitchell MP, Woodward WA, Smith BD, Hoffman KE, Goodman CR, Garber HR, Sun SX, Yap TA, Meric-Bernstam F, Arzu IY, Bloom ES, Schlembach PJ, Strom EA, Stauder MC, Shaitelman SF. Jacomina LE, et al. Among authors: meric bernstam f. Int J Radiat Oncol Biol Phys. 2024 Nov 14:S0360-3016(24)03637-X. doi: 10.1016/j.ijrobp.2024.11.065. Online ahead of print. Int J Radiat Oncol Biol Phys. 2024. PMID: 39549757
A Phase Ib Study of Selinexor in Combination with Pembrolizumab in Patients with Metastatic Melanoma.
Gouda MA, Stephen B, Tian Y, Alshawa A, Onwugaje DOC, Albittar A, Yang Y, Zarifa A, Yilmaz B, Gurses S, Sprenger A, Derbala MH, Brink A, How JA, Moyers J, Piha-Paul SA, Hong DS, Meric-Bernstam F, Patel SP, Oliva IG. Gouda MA, et al. Among authors: meric bernstam f. J Immunother Precis Oncol. 2024 Nov 1;7(4):247-254. doi: 10.36401/JIPO-24-3. eCollection 2024 Nov. J Immunother Precis Oncol. 2024. PMID: 39524469 Free PMC article.
Utilizing Patient-derived Xenografts to Model Precision Oncology for Biliary Tract Cancer.
DiPeri TP, Evans KW, Scott S, Zheng X, Varadarajan K, Kwong LN, Kahle M, Tran Cao HS, Tzeng CW, Vu T, Kim S, Su F, Raso MG, Rizvi Y, Zhao M, Wang H, Lee SS, Yap TA, Rodon J, Javle M, Meric-Bernstam F. DiPeri TP, et al. Among authors: meric bernstam f. Clin Cancer Res. 2024 Nov 8. doi: 10.1158/1078-0432.CCR-24-1233. Online ahead of print. Clin Cancer Res. 2024. PMID: 39513959
Anti-Programmed Death Ligand 1 Plus Targeted Therapy in Anaplastic Thyroid Carcinoma: A Nonrandomized Clinical Trial.
Cabanillas ME, Dadu R, Ferrarotto R, Gule-Monroe M, Liu S, Fellman B, Williams MD, Zafereo M, Wang JR, Lu C, Ning M, McKinley BA, Woodman SE, Duose D, Gunn GB, Busaidy NL; Rare Tumor Initiative Team. Cabanillas ME, et al. JAMA Oncol. 2024 Oct 24:e244729. doi: 10.1001/jamaoncol.2024.4729. Online ahead of print. JAMA Oncol. 2024. PMID: 39446377 Free PMC article.
Efficacy of Trastuzumab Deruxtecan in HER2-Expressing Solid Tumors by Enrollment HER2 IHC Status: Post Hoc Analysis of DESTINY-PanTumor02.
Oaknin A, Lee JY, Makker V, Oh DY, Banerjee S, González-Martín A, Jung KH, Ługowska I, Manso L, Manzano A, Melichar B, Siena S, Stroyakovskiy D, Fielding A, Puvvada S, Smith A, Meric-Bernstam F. Oaknin A, et al. Among authors: meric bernstam f. Adv Ther. 2024 Nov;41(11):4125-4139. doi: 10.1007/s12325-024-02975-x. Epub 2024 Sep 11. Adv Ther. 2024. PMID: 39261417 Free PMC article. Clinical Trial.
A phase I trial of LHC165 single agent and in combination with spartalizumab in patients with advanced solid malignancies.
Curigliano G, Jimenez MM, Shimizu T, Keam B, Meric-Bernstam F, Rutten A, Glaspy J, Schuler PJ, Parikh NS, Ising M, Hassounah N, Wu J, Leyk M, Chen X, Burks H, Chaudhury A, Otero J, Cabanas EG. Curigliano G, et al. Among authors: meric bernstam f. ESMO Open. 2024 Aug;9(8):103643. doi: 10.1016/j.esmoop.2024.103643. Epub 2024 Jul 31. ESMO Open. 2024. PMID: 39088985 Free PMC article. Clinical Trial.
690 results